Unilateral Tamoxifen-Induced Retinopathy as a Consequence of Breast Cancer Treatment—Multimodal Imaging Value by Paulina Szabelska, Katarzyna Paczwa, Joanna Ciszewska, Radosław Różycki, Joanna Gołębiewska

Get full text

Interference of Herbal Medicine with Axitinib in Metastatic Renal Cell Cancer Treatment: A Case Study by Friederike Himmelreich, Alexander Jetter, Michael K. Kiessling, Yannick Kadvany, Andreas Trojan

Get full text

Biodegradable manganese-doped hydroxyapatite antitumor adjuvant as a promising photo-therapeutic for cancer treatment by Sumin Park, Jaeyeop Choi, Vu Hoang Minh Doan, Se Hwi O

Subjects: Get full text

A Targeted Approach to Post-Mastectomy Pain and Persistent Pain following Breast Cancer Treatment by Philip J. Chang, Arash Asher, Sean R. Smith

Get full text

Coactive chemoradiotherapy using polysaccharides- and synthetic polymers-based hydrogels for cancer treatment: A review by Mozhdeh Dolati, Somayeh Vandghanooni, Kazhal Veisi, Mehdi Jaymand

“…Depend on stage and type of cancer as well as the general health of the patient, the most common cancer treatment strategies are surgery, radiotherapy (RT), chemotherapy, and chemoradiotherapy (CRT). …”
Get full text

Racial and Ethnic Variation in Health-Related Quality of Life Scores Prior to Prostate Cancer Treatment by Stephanie R. Reading, PhD, MPH, Kimberly R. Porter, PhD, MPH, Jeffrey M. Slezak, MS, Teresa N. Harrison, SM, Joy S. Gelfond, Gary W. Chien, MD, Steven J. Jacobsen, MD, PhD

“…Racial and Ethnic Variation in Health-Related Quality of Life Scores Prior to Prostate Cancer Treatment. Sex Med 2017;5:e219–e228.…”
Get full text

Co-delivery of sorafenib and metformin from amphiphilic polypeptide-based micelles for colon cancer treatment by Xiaohui Zhang, Xiaohui Zhang, Lanqing Cao, Guangmeng Xu, Hongyu He, Hongyu Zhao, Tongjun Liu

Get full text

PDA/gold nanorod-based nanoparticles for synergistic genetic and photothermal combination therapy for cancer treatment by Guiming Niu, Li Zhao, Yandong Wang, Yanyan Jiang

“…A series of new nanobiotechnology-based methods have been developed toward achieving safe and efficient cancer treatment. Gold nanorods (AuNRs) have attracted increasing attention owing to their unique optical characteristics, good biocompatibility, and low toxicity, and they have thus been widely used in tumor treatment. …”
Get full text

SA 10.4 Breast cancer treatment and research from a Latin American perspective by D. Bretel

Get full text

Switching from Aromatase Inhibitors to Dual Targeting Flavonoid-Based Compounds for Breast Cancer Treatment by Silvia Gobbi, Silvia Martini, Riccardo Rozza, Angelo Spinello, Jessica Caciolla, Angela Rampa, Federica Belluti, Nadia Zaffaroni, Alessandra Magistrato, Alessandra Bisi

Get full text

Business Risk Mitigation in the Development Process of New Monoclonal Antibody Drug Conjugates for Cancer Treatment by Balázs Kiss, János Borbély

Get full text

Role of the pharmacist in the management of postmenopausal breast cancer treatment with vasomotor symptoms: A case report by Megan R. Undeberg, Alanda Barash, Kimberly C. McKeirnan

“…Following implementation, the patient was satisfied to experience minimal hot flashes and relayed full compliance with her breast cancer treatment regimen. Pharmacists can play an important role in the management of postmenopausal breast cancer and vasomotor symptoms by providing patient education and recommending medications based on treatment guidelines with consideration to side effects and drug interactions.…”
Get full text

Computational design of newly engineered DARPins as HER2 receptor inhibitors for breast cancer treatment by Maryam Beheshti Isfahani, Karim Mahnam, Hooria Seyedhosseini-Ghaheh, Hamid Mir Mohammad Sadeghi, Hossein Khanahmad, Vajihe Akbari, Jaleh Varshosaz

“…Background and purpose: Human epidermal growth factor receptor 2 (HER2) is overexpressed in approximately 25% of breast cancer patients; therefore, its inhibition is a therapeutic target in cancer treatment. Experimental approach: In this study, two new variants of designed ankyrin repeat proteins (DARPins), designated EG3-1 and EG3-2, were designed to increase their affinity for HER2 receptors. …”
Get full text

Comorbidity Prevalence and Impact on Quality of Life in Gay and Bisexual Men Following Prostate Cancer Treatment by Ryan Haggart, MD, Elizabeth Polter, MPH, Michael Ross, MD, PhD, Nidhi Kohli, PhD, Badrinath R. Konety, MD, MBA, Darryl Mitteldorf, MSW, William West, PhD, B.R.Simon Rosser, PhD, MPH

“…Introduction: Studies have demonstrated worse health related quality of life (HRQOL) outcomes in gay and bisexual men (GBM) following prostate cancer treatment compared to heterosexual men potentially due to differences in comorbidity burden. …”
Get full text

Optimal control for cancer treatment mathematical model using Atangana–Baleanu–Caputo fractional derivative by Nasser Hassan Sweilam, Seham Mahyoub Al-Mekhlafi, Taghreed Assiri, Abdon Atangana

“…Abstract In this work, optimal control for a fractional-order nonlinear mathematical model of cancer treatment is presented. The suggested model is determined by a system of eighteen fractional differential equations. …”
Get full text

Polysaccharide-Peptide from <i>Trametes versicolor</i>: The Potential Medicine for Colorectal Cancer Treatment by Zhicheng He, Jian Lin, Yingying He, Shubai Liu

“…However, the intricacy and high molecular weight make mechanistic research difficult, which restricts their further application as a medication in clinical cancer treatment. Recent research has discovered a small molecule polysaccharide peptide derived from <i>Trametes versicolor</i> that has a distinct structure after decades of <i>Trametes versicolor</i> investigation. …”
Get full text

LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials by Beatrice Noce, Elisabetta Di Bello, Rossella Fioravanti, Antonello Mai, Antonello Mai

Get full text

Development of BSA conjugated on modified surface of quercetin- loaded lipid nanocarriers for breast cancer treatment by Rahul Kumar, Dhiraj Kumar Choudhary, M Debnath

Get full text

Novel therapeutic strategies targeting myeloid-derived suppressor cell immunosuppressive mechanisms for cancer treatment by Eric Jou, Natasha Chaudhury, Fizza Nasim

“…Methods to deplete MDSCs clinically and inhibit their immunosuppressive function will be crucial in advancing cancer treatment and to overcome treatment resistance. …”
Get full text

Improving the Efficacy of Common Cancer Treatments via Targeted Therapeutics towards the Tumour and Its Microenvironment by Daniel Cecchi, Nolan Jackson, Wayne Beckham, Devika B. Chithrani

“…Radiation therapy is involved in around 50% of cancer treatment workflows; however, it presents significant recurrence rates and normal tissue toxicity, given the inevitable deposition of the dose to the surrounding healthy tissue. …”
Get full text